Related Experiment Video
Updated: Feb 19, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
Global priorities for advancing cancer survivorship
Henry C Y Wong1, Nicolas H Hart2,3, Alexandre Chan4,5
1Department of Oncology, Princess Margaret Hospital, Kowloon West Cluster, Hospital Authority, Hong Kong S.A.R., China.
Purpose Of Review:
Cancer survivorship is increasingly recognized as an important component of cancer care, yet access to high-quality care remains inconsistent globally. This review highlights priorities for advancing survivorship care worldwide, focusing on equity of access, outcomes for vulnerable populations, multidisciplinary models, technology-enabled interventions, and global collaboration.
Recent Findings:
Survivorship needs differ across tumor streams and cancer sub-populations, especially older adults, adolescent, and people with advanced or metastatic cancers who face unique physical, psychosocial, and other practical challenges. Models that involve a variety of clinicians, such as oncologists and hematologists, primary care providers, nurses and allied health providers maintain quality of life, reduce healthcare costs, and support patient preferences, yet most countries still rely on oncologist-led follow-up. Digital health and artificial intelligence have the potential to enhance symptom monitoring, improve patient engagement, and deliver personalized care. Surveys led by the International Psycho-Oncology Society (IPOS) and Multinational Association of Supportive Care in Cancer (MASCC) reveal persistent disparities, particularly in low-income and middle-income countries and communities, highlighting evident gaps in supportive care access, infrastructure, and guideline implementation.
Summary:
Advancing high-quality survivorship care requires embedding equity into research and policy, expanding multidisciplinary and technology-enabled care models, and strengthening global collaboration. Longitudinal studies, region-specific guidelines, and capacity building in low-resource and middle-resource settings are essential. Implementing these strategies can optimize the outcomes and ensure sustainable care delivery for cancer survivors worldwide.
Related Concept Videos
Cancer Survival Analysis
Cancer Prevention
Some...
Treatment Resistant Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies
There are several types of targeted therapies against...
